Fractyl nets $44 mln Series D
Lexington, Massachusetts-based Fractyl Laboratories Inc, a medical tech company, has raised $44 million in Series D financing. The investors included GV, True Ventures, the IDO Fund, General Catalyst, Bessemer Venture Partners, Domain Associates, Mithril Capital Management, Emergent Medical Partners, L.P. and Deerfield Management Company L.P.
30 November 2017•1 min read
